On Registration Review of Continuous Manufacturing Drugs in Foreign Markets and Its Implications

Cao Hui, Ding Licheng, Hu Yanchen, Wang Yamin, Li Xiangyu

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (4) : 377-383.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (4) : 377-383. DOI: 10.16153/j.1002-7777.2022.04.002

On Registration Review of Continuous Manufacturing Drugs in Foreign Markets and Its Implications

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(4): 377-383 https://doi.org/10.16153/j.1002-7777.2022.04.002

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/